Omeros | OMER - Trade Debtors


Omeros reported $8.08M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Adma Biologics USD 137.67M 27.94M Sep/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Immunic USD 1.5M 50K Jun/2024
Insmed USD 140.86M 75.6M Dec/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
MacroGenics USD 69.23M 56.7M Sep/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 124.07M 8.8M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Rockwell Medical USD 10.84M 250K Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025
Xoma USD 14.78M 4.96M Jun/2024